Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Rohde

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Ugeskrift for Laeger|October 9, 2014
[Duodenal-jejunal bypass sleeve - a potential alternative to bariatric surgery?]Ulrich Rohde, Silas Gylvin, Peter Vilmann, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 DiabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Diabetes, Obesity & Metabolism|August 9, 2017
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Gastro Hep Advances|May 11, 2026
Prevalence of Bile Acid Diarrhea and Effect of Budesonide on the Bile Acid Homeostasis in Flare of Microscopic ColitisRuben Due Lorentsen, Christian Borup, Anja Poulsen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 ResponsesUlrich Rohde, David Peick Sonne, Mikkel Christensen, et al.
Diabetes, Obesity & Metabolism|October 4, 2016
The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetesUlrich Rohde, Cecilie A Federspiel, Peter Vilmann, et al.
JCI Insight|December 7, 2018
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetesEmilie Bahne, Emily W L Sun, Richard L Young, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Ugeskrift for Laeger|October 9, 2014
[Duodenal-jejunal bypass sleeve - a potential alternative to bariatric surgery?]Ulrich Rohde, Silas Gylvin, Peter Vilmann, et al.
The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Single-Dose Metformin Enhances Bile Acid-Induced Glucagon-Like Peptide-1 Secretion in Patients With Type 2 DiabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Diabetes, Obesity & Metabolism|August 9, 2017
The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetesAndreas Brønden, Anders Albér, Ulrich Rohde, et al.
Gastro Hep Advances|May 11, 2026
Prevalence of Bile Acid Diarrhea and Effect of Budesonide on the Bile Acid Homeostasis in Flare of Microscopic ColitisRuben Due Lorentsen, Christian Borup, Anja Poulsen, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 ResponsesUlrich Rohde, David Peick Sonne, Mikkel Christensen, et al.
Diabetes, Obesity & Metabolism|October 4, 2016
The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetesUlrich Rohde, Cecilie A Federspiel, Peter Vilmann, et al.
JCI Insight|December 7, 2018
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetesEmilie Bahne, Emily W L Sun, Richard L Young, et al.
Pageof 2